Jibin Liu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 9
- Cancer Genomics and Diagnostics 3
-
- RNA modifications and cancer 12
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 5
- RNA Research and Splicing 3
-
- Ferroptosis and cancer prognosis 9
- Journals
- SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)ACS Applied Materials & Interfaces (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jibin Liu
47 papers receiving 746 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 295
- Molecular Biology 438
- Oncology 158
- Pulmonary and Respiratory Medicine 164
- Hepatology 33
Countries citing papers authored by Jibin Liu
This map shows the geographic impact of Jibin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jibin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jibin Liu more than expected).
Fields of papers citing papers by Jibin Liu
This network shows the impact of papers produced by Jibin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jibin Liu. The network helps show where Jibin Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jibin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 42 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 6 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2021 | 8 |
About Jibin Liu
Jibin Liu is a scholar working on Cancer Research, Aging and Business and International Management, having authored 54 papers that have together received 753 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (9 papers), Ferroptosis and cancer prognosis (9 papers), Circular RNAs in diseases (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer Genomics and Diagnostics (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (295 citations), Molecular Biology (438 citations) and Oncology (158 citations). Jibin Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yu‐Shui Ma, Da Fu, Wen Li, Jing Deng, Jiang Geng, Haimin Lu, Likun Hou, Xiaomei Tang, Sun Feng and Wei Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, Gastroenterology and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.